). Despite the difficulty of obtaining replication results for a complex trait genetic association between blood pressure and hypertension, we were able to identify consistent genetic factors in both the Korean cohorts in ATP2B1, CSK, ARSG and CSMD1 genes.
Blood pressure, one of the important vital signs, is affected by multiple genetic and environmental factors. Recently, several genome-wide association (GWA) studies have successfully identified genetic factors that influence blood pressure and hypertension risk. In this study, we report results of the Korean Association REsource (KARE, 8842 subjects) GWA study on blood pressure and hypertension risk. In all, 10 single-nucleotide polymorphisms (SNPs) that showed significant association with hypertension were further analysed for replication associations in the Health2 project (7861 subjects). Among these 10 SNPs, 3 were replicated in the Health2 cohort for an association with systolic or diastolic blood pressure. The most significant SNP (rs17249754 located in ATPase, Ca þ þ transporting, plasma membrane 1 (ATP2B1)) has been previously reported, and the other two SNPs are rs1378942 in the c-src tyrosine kinase (CSK) gene and rs12945290 in the arylsulphatase G (ARSG) gene. An additional hypertension case-control study confirmed that rs17249754 (in ATP2B1) increases hypertension risk in both the KARE and Health2 (metaanalysis, P-value ¼ 4.25 Â 10
À9
) cohorts. One more SNP, rs995322, located in the CUB and Sushi multiple domains 1 (CSMD1), is also associated with increased risk of hypertension (meta-analysis, P-value ¼ 1.00 Â 10
Introduction
Blood pressure, one of the major vital signs, is affected by multiple, and largely unknown, genes and environmental interactions. Hypertension is defined as blood pressure of X140/90 mm Hg. Approximately 30-50% of blood pressure variability in human hypertension is affected by multiple genetic factors. 1 Twin studies have indicated that the heritable proportion of individual differences in blood pressure can be up to 50%. 2 The obvious cause of hypertension is not known in 95% of cases, but it is considered polygenic, resulting from the accumulation and combination of a number of genetic and environmental risks. Genome-wide association (GWA) studies have been conducted to identify the novel genetic variants associated with complex diseases. 4 The first GWA study on hypertension was conducted by the WTCCC (Wellcome Trust Case Control Consortium). 4 In this study, six single-nucleotide polymorphisms (SNPs) were found to be risk alleles for hypertension status. However, replication studies by the FBPP (Family Blood Pressure Program) 5 and the Korean Association REsource Consortium (KARE) 6 failed to confirm the majority of the findings from WTCCC. In a second GWA study, Wang et al. 7 suggested that the STK39 gene may be a candidate gene for hypertension. A third GWA study on blood pressure and hypertension was conducted by Org et al., 8 who suggested that the CDH13 gene may be a novel susceptibility locus. Previously, we carried out another GWA analysis for anthropometry and blood pressures among Koreans, and discovered a novel variant in the 5 0 -region upstream of the plasma membrane calcium transporting ATPase 1 (ATP2B1) gene. 9 Recently, two more GWA studies for blood pressure and hypertension were conducted by the Global BPgen and CHARGE consortiums, which confirmed the association of the ATP2B1 region on chromosome 12 with hypertension. 10, 11 In this study, we present the replication results of 10 candidate SNPs, which were the most significant hits in the initial KARE GWA study using another Korean cohort (Health2), which comprised 7861 subjects.
Methods

Subjects
The original subjects of the KARE and Health2 cohorts were described in a previous report. 9 Briefly, a total of 8842 subjects were selected from the original KARE cohort. Similarly, 7861 subjects from the Health2 cohort were selected for the present replication analysis on the basis of their clinical information, such as tumour and medication. The geographical location of the KARE and Health2 cohorts was previously described in the study by Cho et al. 9 Briefly, KARE consists of two community-based cohorts grouped on the basis of the Ansung and Ansan regions in Korea. Health2 also consists of community-based cohorts from five different regions (namely Wonju, Pyeong Chang, Gangneung, Geumsan and Naju) in Korea.
Clinical characteristics
The basic characteristics and blood pressure levels of the subjects are described in a previous report 9 and in Table 1 . Briefly, blood pressure measurements were taken thrice in the supine position, and the average was used for this study.
Among the KARE subjects, 1291 were undergoing anti-hypertensive therapy (n ¼ 961) or drug treatments (n ¼ 330) that likely influence blood pressure, and were thus excluded from the quantitative trait analysis. Among the Health2 subjects, 744 were undergoing similar therapies, and were excluded from quantitative trait analysis.
For the case-control study, we defined the normotensive control as systolic blood pressure (SBP) o120 mm Hg and diastolic blood pressure (DBP) o80 mm Hg and the hypertensive cases as SBPX140 mm Hg and/or DBPX90 mm Hg. Subjects undergoing anti-hypertensive therapy (n ¼ 961) were also included in the hypertensive cases. To avoid uncertainty, subjects with pre-hypertensive status (120pSBPo140 and/or 80pDBPo90) were excluded from the case-control study.
Genotyping
Genotypes of the KARE participants, determined using the Affymetrix Genome-Wide Human SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA) in a previous study, 9 were obtained. In this study, we performed genotyping of 7861 subjects for replication analysis. We selected 10 strong signals found to be associated with blood pressures on the basis of initial screening from the GWA scans. Among the 10 SNPs, 1, namely rs17249754, which were reported by Cho et al., 9 were evaluated by an allelic discrimination assay using the TaqMan reaction. Primer Express (Applied Biosystems, Carlsbad, CA, USA) was used to design both the PCR primers and the MGB TaqMan probes. The other eight SNPs, namely rs995322, rs1378942, rs10790381, rs715987, rs12945290, rs12436338, rs879238, rs9515303 and rs7287595, were genotyped using the GoldenGate assay, 12 which is based on a 384 multiplex bead array system (Illumina, San Diego, CA, USA). Detailed experimental procedures can be found in the study by Cho et al. 9 No deviations from HardyWeinberg equilibrium were observed from the genotype frequencies. Duplicate genotyping for approximately 1-2.5% of samples was performed for quality control. Only SNP genotyping results that satisfied the 499% concordance rate in duplicates and the 498% genotype success rate were allowed for subsequent association analyses.
Statistics
Most statistical analyses were performed using PLINK version 1.06 13 and SAS programs (version 9.1; SAS Institute, Cary, NC, USA). SBP and DBP were tested for association with hypertension by linear regression analysis with an additive model (1 d.f.) after adjustment for region, age, sex and body mass index. Normotensive controls and hypertensive cases were tested for association using logistic 
Results
Selection of 10 SNPs for replication study A total of 10 SNPs listed in Table 2 were selected on the basis of the P-value (o6.0 Â 10 À4 ) of the association analysis with SBP and DBP in the supine position. Among these, two SNPs (rs715987 and rs17249754) were previously reported. 9 The association plots in the 10 loci flanking the significant SNPs are depicted in Figure 1 .
For the replication study, the 10 selected SNPs were genotyped among 7861 individuals from the Health2 cohort. The age of the subjects ranged from 40 to 69 years, similar to participants in the cohorts from the Ansung and Ansan areas recruited in the KARE study. No indication of a deviation from Hardy-Weinberg equilibrium was found at any of these markers in either the KARE GWA samples or in the Health2 replication samples (data not shown).
Quantitative trait analysis
Results of multiple linear regression analysis for SBP and DBP are shown in Table 2 along with the results of the meta-analysis. Three SNPs were significantly associated in the replication subjects with SBP and/or DBP. The most significant SNP in the Health2 cohort was rs17249754, which has been previously reported 9 (for SBP
Case-control analysis
In addition to the association with high blood pressure, hypertension risk associated with the 10 SNPs was evaluated in both the KARE and Health2 cohorts as the case-control analysis was not carried out in the previous report. 9 Our data from the multiple logistic regression analysis for hypertension, along with meta-analysis, is described in Table 3 . Two SNPs were significantly associated in both cohorts. The rs17249754 showed an association ). Another SNP, rs995322, showed a significant association with hypertension risk in the KARE cohort (odds ratio ¼ 1.13, confidence interval: 1.04-1.24, P ¼ 5.17 Â 10
À3
) and also in the Health2 cohort (odds ratio ¼ 1.15, confidence interval: 1.03-1.27, P ¼ 9.60 Â 10
).
Discussion
We identified a total of 4 SNPs (namely rs17249754, rs1378942, rs12945290 and rs995322) that seem to be associated with blood pressure or hypertension in 7861 subjects from the Health2 and 8842 KARE subjects. Although most of the detected P-values were not significant after Bonferroni's correction, the strongest SNP, rs17249754 remained significant after the correction. The SNP rs17249754 is located in chromosome position 12q21.33 in ATP2B1, which belongs to the family of P-type primary ion transport ATPases. In the current replication study, rs17249754 showed significant association signals with all three blood pressure traits (such as SBP, DBP and hypertension). The biological function of ATP2B1 involves the homeostasis of cellular calcium ion levels, which is known to control vascular smooth muscle contraction and dilation. 14, 15 The SNP rs1378942 is located in the first intron of CSK (c-src tyrosine kinase) at chromosome position 15q23-25. Our results showed that rs1378942 is associated with SBP in both cohorts (meta-analysis, P ¼ 1.34 Â 10 À5 ). Src kinases are a family of nonreceptor tyrosine kinases that are widely expressed in human tissues. 16 To date, at least 14 members have been identified, of which 60-kDa c-Src is the prototype. 16 Of the many Src kinases, c-Src is highly expressed in vascular smooth muscle cells. 17 It is also rapidly activated by angiotensin II and has a key role in signalling events associated with vascular smooth muscle cell contraction, growth and migration. [18] [19] [20] Recent GWA studies by Global BPgen and CHARGE consortiums presented similar results with regard to the association of this SNP with blood pressure, strongly suggesting a link between CSK genetic variation and blood pressure.
The SNP rs12945290 is located in the seventh intron of ARSG (arylsulphatase G) at chromosome position 17q24.2. rs12945290 showed association with DBP in both the cohorts (meta-analysis, P ¼ 6.13 Â 10 À5 ). Sulphatases hydrolyse sulphate esters from sulphated steroids, carbohydrates, proteoglycans and glycolipids, 21 and are involved in hormone biosynthesis, modulation of cell signalling and in the degradation of macromolecules. 21 ARSG is a novel arylsulphatase and acts on pseudosubstrates, including p-nitrocatechol sulphate and 4-methylumbelliferyl sulphate. 22 The protein accumulates within lysosomes and is also a glycoprotein that binds specifically to mannose 6-phosphate receptors. 22 ARSG mRNA expression was found to be tissue-specific with the highest expression in the liver, kidney and pancreas, suggesting a metabolic role of ARSG. 23 The SNP rs995322 is located in the eleventh intron of CSMD1 (CUB and Sushi multiple domains 1) at chromosome position 8p23.2. rs995322, although not associated with blood pressure, showed significant association signals with hypertension in casecontrol studies in both the cohorts (meta-analysis, P ¼ 1.00 Â 10
À4
). CSMD1 is a putative suppressor of squamous cell carcinomas of the head and neck, 24 and the gene encodes a 389-kDa transmembrane protein named for its repeated CUB and sushi domains. 24 Both CUB and sushi domains are found in many other proteins and are believed to be sites of either proteinprotein or protein-ligand interactions. 25, 26 At this moment, it is not clear how CSMD1 would contribute to blood pressure regulation.
As blood pressure is controlled by multiple genes and is influenced by various environmental contexts, few attempts have been made for a GWA replication study. The recent Global BPgen and CHARGE GWA studies reported rs17249754 and rs1378942 as risk factors for blood pressure with replication in other cohorts. 10, 11 Interestingly, these two loci, which encode ATP2B1 and CSK, respectively, have been shown to be associated with blood pressure control and hypertension in our replication study. These results imply the importance of ATP2B1 and CSK in blood pressure regulation and hypertension aetiology, thereby emphasizing the importance of carrying out further investigations to clarify the functional basis of the associations.
In this study, we report the presence of consistent genetic factors ATP2B1, CSK, ARSG and CSMD1, which have been shown to be associated with high blood pressure and hypertension in two Korean cohorts. However, we cannot exclude the possibility that the associated SNPs in this study might be in tight linkage disequilibrium with other causative genes. Our findings provide a better understanding of the mechanism underlying the development of hypertension. However, because of the complex nature of the genetic architecture, our results also show the difficulties of replication studies on blood pressure and hypertension.
